Search results
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Morningstar· 6 days agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 & ...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters· 6 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days agoFurther, Moderna confirmed it's in discussions with the U.S. government to move forward with its...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe company recently reported positive data from the Phase III combination vaccine trial....
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 6 days ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 6 days agoAt this time, mRNA-1083 is poised to be the first Covid-19/influenza combination vaccine and the...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 7 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 5 days agoModerna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher efficacy in adults age 18 and older ...